Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
HT-1376
Cat.No.: CSC-C9439L
Species: Homo sapiens (human)
Morphology: epithelial
Culture Properties: monolayer
- Specification
- Q & A
- Customer Review
Tumorigenecity: yes, in mice and hamsters
Isoenzyme: G6PD,B
Production: fibrinolytic activity; interferon
Histopathology: carcinoma; cancer; Grade 3
Note: the line does not contain detectable virus particles, herpesvirus antigens or retrovirus antigens; the cells will grow in soft agar
vWA: 15,18
FGA: 21,22
Amelogenin: X
TH01: 7,9.3
TPOX: 8
CSF1P0: 12
D5S818: 11,12
D13S317: 9,11
D7S820: 9,12
We recommend 40×, 100× and 200×.
Ask a Question
Average Rating: 5.0 | 1 Scientist has reviewed this product
Stable growth
Stable growth state by transporting cell products with dry ice.
04 Feb 2022
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: These cells were thought to be "stablished from the malignant urinary bladder carcinoma of a 66-year-old Caucasian man (stage pTa G3) in 1989"; same donor as for cell line BT-A; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA
Description: These cells were thought to be "established from the malignant urinary bladder carcinoma of a 82-year-old Caucasian woman (stage pTa G1-G2) in 1992"; same donor as for cell line SBC-7; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA
Description: These cells were thought to be "established from the malignant urinary bladder carcinoma of a 82-year-old Caucasian woman (stage pTa G1-G2) in 1992"; same donor as for cell line SBC-2; however, DNA fingerprinting and cytogenetic analysis at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA
Description: Established from a 51-year-old Chinese woman with a grade III papillary transitional cell carinoma of the urinary bladder in 1990; patient lived in a blackfoot disease endemic area in Taiwan
Description: Established from the tumor specimen resected from the urinary bladder transitional cell carcinoma (undifferentiated, grade IV) of a 67-year-old woman in 1974 (without therapy)
Description: Established from the invasive transitional cell carcinoma of the bladder (grade 3, pT3b) of a 76-year-old man in 1993; described as secreting several hematopoietic cytokines and chorionic gonadotropin
